MDS Analytical Technologies, a leader in innovative solutions for drug discovery and life-sciences research, today announced that the Abraxis Melamine Detection Kit has been validated for use on MDS Analytical Technologies’ SpectraMax® absorbance microplate readers with SoftMax® Pro 5 GxP analytical software, an industry-standard analysis software for FDA 21 CFR Part 11 compliance.
Navigation
Daily News
- Job Seekers With Disabilities Face Discrimination At Application Stage, UK
- Terrence Higgins Trust Scotland Urges Young Men In Argyll & Bute To Test For Chlamydia And Gonorrhoea
- Double Success For Instituto Gulbenkian De Ciencia Scientists Working On Chromosome Segregation
- The Very First All Spanish "Surgery Robot" Is Now Operating In Malaga
- Undiagnosed Celiac Disease More Common Today Than 50 Years Ago Say US Researchers
Translator
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() | ![]() |
![]() | ![]() | ||||||||
| By N2H | |||||||||









































